In vitro action of combined salbutamol and theophylline on anaphylactic contractions, mediator release and cyclic 3',5'-adenosine monophosphate in lung parenchyma.
The mechanisms involved in the anti-asthmatic action of combined bronchodilator therapy was studied by determining the effects of combined salbutamol and theophylline on anaphylactic contractions, histamine release, prostaglandin (PG)F2 ALha release, cyclic 3',5'-adenosine monophosphate (c-AMP) and smooth muscle tone in guinea-pig peripheral airways in vitro. Combined, salbutamol (3 X 10(=8) M) and theophylline (3 X 10(-4) M) markedly inhibited anaphylactic contractions (85.8%) in lung strips. The inhibition of anaphylactic contractions was significantly greater than inhibition of histamine and PGF2 alpha-induced contractions. Histamine release was reduced by 66.1% but PGF2 alpha was not significantly altered. Increased c-AMP was observed with combined salbutamol (3 X 10(-8) M) and theophylline (3 X 10(-4) M) in the absence of antigen. The combined effect of salbutamol and theophylline was always greater than the sum of their individual effects. The results demonstrate that in peripheral airways theophylline potentiates the action of salbutamol both directly via smooth muscle relaxation and indirectly via inhibition in mediator release.
D000420:Albuterol / Q000494:pharmacology*; D000707:Anaphylaxis / Q000503:physiopathology*; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism; D006168:Guinea Pigs; D006636:Histamine Release / Q000187:drug effects; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D008168:Lung / Q000187:drug effects* / Q000378:metabolism; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D011460:Prostaglandins F / Q000378:metabolism; D011506:Proteins / Q000378:metabolism; D013806:Theophylline / Q000494:pharmacology*
D011460:Prostaglandins F; D011506:Proteins; D013806:Theophylline; D000242:Cyclic AMP; D000420:Albuterol; D007213:Indomethacin